Ignite Creation Date:
2025-12-25 @ 4:09 AM
Ignite Modification Date:
2026-02-25 @ 9:36 PM
Study NCT ID:
NCT02079220
Status:
WITHDRAWN
Last Update Posted:
2017-07-31
First Post:
2014-03-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer
Sponsor:
James J Lee
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-03
Start Date Type:
None
Primary Completion Date:
2018-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-03
Completion Date Type:
ESTIMATED
First Submit Date:
2014-03-03
First Submit QC Date:
None
Study First Post Date:
2014-03-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-26
Last Update Post Date:
2017-07-31
Last Update Post Date Type:
ACTUAL